| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Section of Molecular Cell Biology, Department of Cancer Biology [W. X., Y-K. L., M-C. H.], Sections of Cytology, Departments of Pathology [H-Z. Z., R. L. K.] and Biomathematics [D. A. J.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Center of Infectious Disease, School of Public Health, University of Texas, Houston, Texas 77030 [F-Y. X.]; and Department of Oral Pathology, Ninth People’s Hospital, Shanghai Second Medical University, Shanghai 200021, People’s Republic of China [A-R. L., L. L.]
In a series of 111 patients with squamous cell carcinoma (SCC), we used immunohistochemistry to examine the expression levels of four epidermal growth factor receptor (EGFR) family members (EGFR, HER-2/neu, HER-3, and HER-4). Expression of the EGFR members was not significantly associated with tumor size. However, their expressions (except for HER-4) were significantly associated with the presence of lymph node metastasis, and all of them were significantly associated with distant metastasis. We further examined the association between the expression levels of the EGFR members and the survival rates in 47 oral SCC patients whose detailed clinical follow-ups were available. The expression of all EGFR members was significantly associated with shortened patient survival, and the association was strongest for HER-2/neu. Furthermore, the combination of HER-2, HER-3, and EGFR but not HER-4 significantly improved the predicting power. The expression level of HER-2/neu was significantly correlated with that of EGFR or HER-3. Similar coexpression patterns were also observed in three oral SCC cell lines studied, but not in four other head and neck SCC cell lines. Taken together, these results indicated that expression levels of EGFR, HER-2/neu, and HER-3 may help predict the outcome of patients with oral SCC.
This article has been cited by other articles:
|
|
 |
|
  C M West, L Joseph, and S Bhana Epidermal growth factor receptor-targeted therapy Br. J. Radiol., October 1, 2008; 81(Special_Issue_1): S36 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Gonzales, K. E. Hook, I. W. Althaus, P. A. Ellis, E. Trachet, A. M. Delaney, P. J. Harvey, T. A. Ellis, D. M. Amato, J. M. Nelson, et al. Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor Mol. Cancer Ther., July 1, 2008; 7(7): 1880 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Erjala, M. Sundvall, T. T. Junttila, N. Zhang, M. Savisalo, P. Mali, J. Kulmala, J. Pulkkinen, R. Grenman, and K. Elenius Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells. Clin. Cancer Res., July 1, 2006; 12(13): 4103 - 4111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Benlimame, Q. He, S. Jie, D. Xiao, Y. J. Xu, M. Loignon, D. D. Schlaepfer, and M. A. Alaoui-Jamali FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion J. Cell Biol., November 7, 2005; 171(3): 505 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Christensen, P. W. Vincent, W. D. Klohs, D. W. Fry, W. R. Leopold, and W. L. Elliott Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor Mol. Cancer Ther., June 1, 2005; 4(6): 938 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Baselga and C. L. Arteaga Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer J. Clin. Oncol., April 10, 2005; 23(11): 2445 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.-F. Huang, and M.-C. Hung Novel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer Cancer Res., January 1, 2005; 65(1): 338 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Britten Targeting ErbB receptor signaling: A pan-ErbB approach to cancer Mol. Cancer Ther., October 1, 2004; 3(10): 1335 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Herbst and P. A. Bunn Jr. Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5813 - 5824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masuda, M. Suzui, J. T. E. Lim, and I. B. Weinstein Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells Clin. Cancer Res., August 1, 2003; 9(9): 3486 - 3491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Alaoui-Jamali, D. J. Song, N. Benlimame, L. Yen, X. Deng, M. Hernandez-Perez, and T. Wang Regulation of Multiple Tumor Microenvironment Markers by Overexpression of Single or Paired Combinations of ErbB Receptors Cancer Res., July 1, 2003; 63(13): 3764 - 3774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Grunwald and M. Hidalgo Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment J Natl Cancer Inst, June 18, 2003; 95(12): 851 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Arteaga and J. Baselga Clinical Trial Design and End Points for Epidermal Growth Factor Receptor-targeted Therapies: Implications for Drug Development and Practice Clin. Cancer Res., May 1, 2003; 9(5): 1579 - 1589. [Full Text] [PDF]
|
|
|
|
|
|
Y. Ding, Y. Wen, B. Spohn, L. Wang, W. Xia, K. Y. Kwong, R. Shao, Z. Li, G. N. Hortobagyi, M.-C. Hung, et al. Proapoptotic and Antitumor Activities of Adenovirus-mediated p202 Gene Transfer Clin. Cancer Res., October 1, 2002; 8(10): 3290 - 3297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Arteaga Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression? Oncologist, August 15, 2002; 7(90004): 31 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Piyathilake, A. R. Frost, U. Manne, H. Weiss, W. C. Bell, D. C. Heimburger, and W. E. Grizzle Differential Expression of Growth Factors in Squamous Cell Carcinoma and Precancerous Lesions of the Lung Clin. Cancer Res., March 1, 2002; 8(3): 734 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deng, F. Kloosterbooer, W. Xia, and M.-C. Hung The NH2-Terminal and Conserved Region 2 Domains of Adenovirus E1A Mediate Two Distinct Mechanisms of Tumor Suppression Cancer Res., January 1, 2002; 62(2): 346 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-W. Lai, F.-F. Chen, M.-H. Wu, N.-H. Chow, W.-C. Su, M.-C. Ma, P.-F. Su, H. Chen, M.-Y. Lin, and Y.-L. Tseng Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Ann. Thorac. Surg., December 1, 2001; 72(6): 1868 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Christensen, R. E. Schreck, E. Chan, X. Wang, C. Yang, L. Liu, J. Cui, L. Sun, J. Wei, J. M. Cherrington, et al. High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo Clin. Cancer Res., December 1, 2001; 7(12): 4230 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Arteaga The Epidermal Growth Factor Receptor: From Mutant Oncogene in Nonhuman Cancers to Therapeutic Target in Human Neoplasia J. Clin. Oncol., September 15, 2001; 19(90001): 32s - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-H. Chow, S.-H. Chan, T.-S. Tzai, C.-L. Ho, and H.-S. Liu Expression Profiles of ErbB Family Receptors and Prognosis in Primary Transitional Cell Carcinoma of the Urinary Bladder Clin. Cancer Res., July 1, 2001; 7(7): 1957 - 1962. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
